| 30.06.2022 17:36:08 | |
|---|---|
| Cena | |
| 168,00 CHF | |
| Změna | 15,86% (23,00) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | SIX Swiss Exchange |
| Měna | CHF |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 434.587 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 168,00 CHF (15) |
| Prodej (částka) | 135,00 CHF (2) |
| Otevírací cena | 168,00 CHF |
| Max | 168,00 CHF |
| Min | 168,00 CHF |
| Závěrečná cena (předchozí den) | 145,00 CHF |
| Cena vážená obchodovaným objemem | 154,03 CHF |
| Objem (kusy) | - |
| Obchodovaný objem | - |
| Počet obchodů | 1 |
| Poslední zobchodovaný počet | - |
Futures a opce
| Související Futures | 15 |
| Související Opce | - |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON |  |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Aktuální analýzy a prognózy
| Datum | Nadpis | Stáhnout | |
| 18.08.2022 |
|
Global Equity Ratings |
|
| 08.08.2022 |
|
Global Equity Ratings |
|
| 25.07.2022 |
|
Global Equity Ratings |
|
| 19.07.2022 |
|
Global Equity Ratings |
|
| 29.06.2022 |
|
Global Equity Ratings |
|
Všechny burzy pro JOHNSON & JOHNSON
| Burza | Datum | Čas | Cena | Obchodovaný objem (mil.) | Počet obchodů |
| Xetra | 19.08.2022 | 12:18 | 165,40 EUR | 0,10 | 69 |
| Vienna Stock Exchange | 19.08.2022 | 09:05 | 164,98 EUR | 0,00 | 1 |
| Tradegate | 19.08.2022 | 12:17 | 165,70 EUR | 0,46 | 60 |
| Stuttgart | 19.08.2022 | 08:50 | 164,68 EUR | 0,00 | 2 |
| SIX Swiss Exchange | 30.06.2022 | 17:36 | 168,00 CHF | 0,00 | 1 |
| SIX Swiss Exchange | 30.03.2020 | 17:35 | 150,00 USD | 0,00 | 1 |
| NYSE | 18.08.2022 | 22:00 | 166,77 USD | 1.387,99 | 69.234 |
| Munich | 19.08.2022 | 08:00 | 165,26 EUR | 0,00 | 1 |
| London Stock Exchange | 18.08.2022 | 17:35 | 165,42 USD | 0,00 | 12 |
| Hanover | 19.08.2022 | 08:08 | 165,16 EUR | 0,00 | 1 |
| Hamburg | 19.08.2022 | 08:56 | 165,12 EUR | 0,01 | 3 |
| Frankfurt | 19.08.2022 | 12:06 | 165,52 EUR | 0,09 | 13 |
| Duesseldorf | 19.08.2022 | 11:01 | 164,72 EUR | 0,00 | 4 |
| Berlin | 19.08.2022 | 12:10 | 165,88 EUR | 0,01 | 2 |
| 30.06.2022 17:36:08 | |
|---|---|
| Cena | |
| 168,00 CHF | |
| Změna | 15,86% (23,00) |
Základní údaje
| ISIN | US4781601046 |
| Symbol | JNJ |
| Burza | SIX Swiss Exchange |
| Měna | CHF |
| Sektor | Chemical / Pharmaceutical / Health |
| Typ cenného papíru | Akcie |
| Tržní kapitalizace (mil.) | 434.587 EUR |
| Benchmark | S&P 500 |
Tržní data
| Nákup (částka) | 168,00 CHF (15) |
| Prodej (částka) | 135,00 CHF (2) |
| Otevírací cena | 168,00 CHF |
| Max | 168,00 CHF |
| Min | 168,00 CHF |
| Závěrečná cena (předchozí den) | 145,00 CHF |
| Cena vážená obchodovaným objemem | 154,03 CHF |
| Objem (kusy) | - |
| Obchodovaný objem | - |
| Počet obchodů | 1 |
| Poslední zobchodovaný počet | - |
Výkonnost a riziko
| 6m | 1r | 3r | |
| Výkonn. (%) | - | - | +21,89% |
| Výkonn. (abs.) | - | - | +30,17 |
| Beta | 0,31 | 0,30 | 0,62 |
| Volatilita | - | - | 23,14 |
Stupnice: ABS REL
Nástroj/produkt
Přidat benchmark:
Minulá výkonnost nezaručuje výkonnost budoucí.Zdroj: FactSet
Ceny
| Ø cena 5 dní| Ø objem 5 dní (ks.) | 33,60 CHF (170.671) |
| Ø cena 30 dní| Ø objem 30 dní (ks.) | 112,40 CHF (42.570) |
| Ø cena 100 dní| Ø objem 100 dní (ks.) | 127,81 CHF (13.022) |
| Ø cena 250 dní| Ø objem 250 dní (ks.) | 130,76 CHF (9.155) |
| YTD Max| datum | 168,00 CHF (30.06.2022) |
| YTD Min | datum | 168,00 CHF (30.06.2022) |
| 52týdenní max. | datum | 168,00 CHF (30.06.2022) |
| 52týdenní min. | datum | 168,00 CHF (30.06.2022) |
Logo společnosti
Kontakty
| JOHNSON & JOHNSON |
| - - |
| One Johnson & Johnson Plaza - 08933 New Brunswick |
| Telefon:1-732-524-0400 |
| Fax:- |
| E-mail:- |
PDF ke stažení
| Report společnosti: JOHNSON & JOHNSON | |
Profil společnosti
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer Health, Pharmaceutical, and Medical Devices. The Consumer Health segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas, such as immunology, infectious diseases, neuroscience, oncology, pulmonary hypertension, and cardiovascular & metabolic diseases. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular & neurovascular, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ. |
Členové představenstva
| Alex Gorsky | Chairman of Board of Directors |
| A. Washington | Member of Board of Directors |
| Jennifer Doudna | Member of Board of Directors |
| Mark McClellan | Member of Board of Directors |
| Mary Beckerle | Member of Board of Directors |
| Nadja West | Member of Board of Directors |
| Anne Mulcahy | Member of Board of Directors |
| D. Davis | Member of Board of Directors |
| Darius Adamczyk | Member of Board of Directors |
| Hubert Joly | Member of Board of Directors |
| Ian Davis | Member of Board of Directors |
| Marillyn Hewson | Member of Board of Directors |
| Mark Weinberger | Member of Board of Directors |
| Joaquin Duato | Chairman of Managing Board |
| Mathai Mammen | Member of Executive Committee |
| Peter M. Fasolo | Member of Executive Committee |
| William N. Hait | Member of Executive Committee |
| Ashley McEvoy | Member of Executive Committee |
| James Swanson | Member of Executive Committee |
| Jennifer Taubert | Member of Executive Committee |
| Joseph Wolk | Member of Executive Committee |
| Kathryn E. Wengel | Member of Executive Committee |
| Michael H. Ullmann | Member of Executive Committee |
| Thibaut Mongon | Member of Executive Committee |
| Vanessa Broadhurst | Member of Executive Committee |